CSMS #53300810
PGA UpdateLow urgency

Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code

CSMS # 53300810 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code U.S. Customs and Border Protection sent this bulletin at 09/16/2022 08:34 AM EDT CSMS # 53300810 - Food and Drug Administration (FDA) New Center for Drug Evaluation and Research (CDER) Product Code The Food and Drug Administration (FDA) has created a new Center for Drug Evaluation and Research (CDER) product code listed below. It is available immediately. Product Code/Description 61F[][]63/Rifaximin (A-Bacterial Pt. I) (Not Antibiotic) Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov For assistance with product code identification, the public may also refer to the FDA Product Code Builder .

Additional Information

Programs Affected:
ACE
PGAs Affected:
FDA